A phase II study of thioTEPA in children with recurrent solid tumor malignancies: a Children's Cancer Group study. (Q33496977)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8824353%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

title

A phase II study of thioTEPA in children with recurrent solid tumor malignancies: a Children's Cancer Group study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8824353%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8824353%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

author name string

J R Geyer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8824353%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

M D Krailo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8824353%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

R Heideman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8824353%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

E Broxson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8824353%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

J K Sato

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8824353%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

D Poplack

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8824353%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

W A Bleyer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8824353%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

publication date

1 January 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8824353%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

19 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8824353%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8824353%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8824353%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

page(s)

337-342

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8824353%20AND%20SRC:MED&resulttype=core&format=json

Designs for group sequential phase II clinical trials.

19 October 2019

cites work

1 reference

12 December 2020

One-day VATH (vinblastine, Adriamycin, thiotepa, and Halotestin) therapy for advanced breast cancer refractory to chemotherapy

1 reference

12 December 2020

Single and repeated dose pharmacokinetics of thio-TEPA in patients treated for ovarian carcinoma

1 reference

12 December 2020

Phase I and pharmacokinetic evaluation of thiotepa in the cerebrospinal fluid and plasma of pediatric patients: evidence for dose-dependent plasma clearance of thiotepa.

1 reference

12 December 2020

Intravesical chemotherapy

1 reference

12 December 2020

Treatment of neoplastic meningitis with intraventricular thiotepa and methotrexate

1 reference

12 December 2020

Confidence intervals following group sequential tests.

1 reference

12 December 2020

High-dose N,N',N"-triethylenethiophosphoramide (thiotepa) with autologous bone marrow transplantation: phase I studies.

1 reference

12 December 2020